A carregar...
Review of Biosimilar Trials and Data on Adalimumab in Rheumatoid Arthritis
PURPOSE OF REVIEW: Adalimumab is one of the top-selling drugs worldwide. Its imminent patent expiration has seen the emergence of numerous biosimilar agents. In this article, we recap the evidence from bio-originator trials in rheumatoid arthritis (RA) to provide context for a critical review of bio...
Na minha lista:
| Publicado no: | Curr Rheumatol Rep |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer US
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6097048/ https://ncbi.nlm.nih.gov/pubmed/30094742 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11926-018-0769-6 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|